A Comparison of Two Socket Sealing Collagen Matrices for Extraction Socket Management

February 18, 2020 updated by: McGuire Institute

A Prospective, Randomized, Controlled, Multi-center Evaluation of Extraction Socket Management Comparing Two Socket Sealing Collagen Matrices

A prospective RCT of intact extractions with delayed implant placement comparing extraction socket management effectiveness and office economics of two collagen matrices. Soft tissue wound healing will be assessed out to 4-months post-operative, when implants will be placed.

Study Overview

Detailed Description

A prospective, randomized, multi-center, controlled clinical study of intact extractions (bony dehiscences <1/3 socket apico-coronal and mesial-distal dimension) with delayed implant placement. Study objective: to compare extraction socket management effectiveness and office economics of a frequently used wound dressing (control) with a soft tissue augmentation matrix (test) in 32-64 subjects 18 -75 years of age with intact (bony dehiscence, if present, < 1/3 socket dimension) extractions intended for dental implant replacement. Following screening subjects will undergo tooth extraction and randomization to either the control or test therapy. After treatment, subjects will be followed until 4- months, the time of implant placement. Primary outcome: soft tissue wound healing measured by (1) gap closure and (2) graft containment at all time points.

Study Type

Interventional

Enrollment (Anticipated)

64

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Fenton, Michigan, United States, 48430
        • Recruiting
        • Seven Lakes Periodontics
        • Contact:
        • Sub-Investigator:
          • Rick Heard, DDS
        • Sub-Investigator:
          • Jim Janakievski, DDS
        • Sub-Investigator:
          • Marc Nevins, DDS
        • Sub-Investigator:
          • Brian Pope, DDS
        • Sub-Investigator:
          • Gregory Toback, DDS
        • Sub-Investigator:
          • Chris Richardson, DMD
        • Principal Investigator:
          • Diego Velasquez, DDS, MSD
        • Sub-Investigator:
          • Don Clem, DDS
        • Sub-Investigator:
          • Michael Pikos, DDS
        • Sub-Investigator:
          • Pamela McClain, DDS
        • Sub-Investigator:
          • Michael McGuire, DDS
        • Sub-Investigator:
          • Craig Misch, DDS, MDS
        • Principal Investigator:
          • Greg Santarelli, DDS
        • Sub-Investigator:
          • Rachel Schallhorn, DDS, MS
        • Sub-Investigator:
          • Eric T Scheyer, DDS, MS
        • Sub-Investigator:
          • Stephen Pickering, DDS, MSD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Subject indicated for anterior tooth extraction (from premolars forward) intended for implant placement.
  • Subjects with essentially intact extraction sockets - bony dehiscences < 1/3 the depth of socket and mesial-distal width of tooth socket
  • Subjects will have read, understood and signed an institutional review board (IRB) approved Informed Consent Form (ICF).
  • Subjects must be able and willing to follow study procedures and instructions

Exclusion Criteria:

  • Subjects with healing disorders (i.e., diabetes mellitus, cancer, HIV, bone metabolic diseases) that could compromise wound healing and/ or preclude implant surgery; or who are currently receiving or have received within two months prior to study entry, systemic corticosteroids, immunosuppressive agents, radiation therapy, and/or chemotherapy which could compromise wound healing and preclude periodontal surgery.
  • Subjects taking intramuscular or intravenous bisphosphonates.
  • Subjects who have a known allergy or sensitivity to collagen.
  • Subjects with acute, suppurative lesions with pain, swelling and apical lesions > 5mm will be excluded, though antibiotic prophylaxis may be employed to reduce infection and provide possible subject reconsideration for inclusion.
  • Heavy smokers/tobacco users defined as those smoking ≥ 10 cigarettes or ≥ 4 cigars or ≥ 4 pipes per day. For non-heavy smokers, smoking ≥ 10 cigarettes or ≥ 4 cigars or ≥ 4 pipes per day is prohibited for the duration of the study.
  • Female subjects who are pregnant or lactating, or who intend to become pregnant during the study duration
  • Subjects participating in other clinical studies involving therapeutic intervention (either medical or dental).
  • Subjects, who in the opinion of the Investigator, for any reason other than those listed above, will not be able to complete the study per protocol.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Collagen Wound Dressing
Bovine collagen sponge used to control bleeding, stabilize blood clots and protect dental wounds
Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic and local anesthetic, minimally traumatic extraction will be performed with periotomes . After degranulation and bone graft placement, control or test biomaterial will be placed according to the randomization schedule and surgical instructions for each biomaterial.
Active Comparator: Test Collagen Matrix
Bilayer, porcine collagen matrix for soft tissue regeneration used as a socket seal in extraction socket grafting
Following resolution of any periodontal issues in the region of study and administration of pre-surgical antibiotic and local anesthetic, minimally traumatic extraction will be performed with periotomes . After degranulation and bone graft placement, control or test biomaterial will be placed according to the randomization schedule and surgical instructions for each biomaterial.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socket Soft Tissue Gap Closure - linear measures buccal-lingual in millimeters
Time Frame: 4-months
Longitudinal extraction socket soft tissue gap closure measured buccal-lingual from baseline to 4-months.
4-months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socket Soft Tissue Gap Closure - linear measures mesial-distal
Time Frame: 4-months
Longitudinal extraction socket soft tissue gap closure measured mesial-distal from baseline to 4-months.
4-months
Graft Containment as observed by subject and examiner (yes/ no)
Time Frame: 4-months
4-months
Inflammation Score (Loe and Sillness)
Time Frame: 4-months
4-months
Biomaterial Integrity - 4-point scale
Time Frame: 4-months
Score 0-4, 0 = biomaterial completely present, 4 = no evidence of biomaterial/ complete granulation or other tissue
4-months
Tissue Thickness - probe show-thru at baseline and biopsy measure in millimeters at 4-months
Time Frame: 4-months
Soft tissue thickness is measured using probe "show-thru" (tissue transparency) at baseline and soft tissue biopsy at the implant site immediately prior to implant placement
4-months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Todd V Scantlebury, BS, The McGuire Institute

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2016

Primary Completion (Anticipated)

April 1, 2020

Study Completion (Anticipated)

June 1, 2020

Study Registration Dates

First Submitted

December 18, 2016

First Submitted That Met QC Criteria

December 22, 2016

First Posted (Estimate)

December 28, 2016

Study Record Updates

Last Update Posted (Actual)

February 20, 2020

Last Update Submitted That Met QC Criteria

February 18, 2020

Last Verified

February 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • GPNA0001-2016

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tooth Loss

Clinical Trials on Control Collagen Wound Dressing

Subscribe